{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:50:59Z","timestamp":1767927059265,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:p>\n                    Major salivary gland carcinomas (MSGCs) is a rare but aggressive cancer, with limited understanding of its metabolic underpinnings. Lipid metabolism, particularly fatty acid metabolism ratios (FAMRs), has been implicated in various cancers, but its role in MSGCs remains unclear. This study aims to explore the potential causal relationships between specific FAMRs and MSGCs using Mendelian randomization (MR) analysis. A 2-sample MR analysis was conducted using summary data from genome-wide association studies. Three FAMRs, including the ratio of diacylglycerol to triglycerides (DAG\/TG), total cholesterol (TC) to total lipids (TL) ratio in large very low-density lipoprotein (VLDL; TC\/TL in large VLDL), and triglycerides to total lipids ratio in medium VLDL (TG\/TL in medium VLDL), were investigated for their potential causal relationships with MSGCs. Sensitivity analyses, including MR-Egger and leave-one-out tests, were performed to assess pleiotropy and the robustness of the results. The DAG\/TG and TC\/TL ratios in large VLDL were significantly positively associated with an increased risk of MSGCs (OR\u2005=\u200510.921,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.004 and OR\u2005=\u20052.651,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.047, respectively). In contrast, the TG\/TL ratio in medium VLDL showed a significant negative association with MSGCs risk (OR\u2005=\u20050.460,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.041). Sensitivity analyses confirmed the robustness of these associations, with no evidence of significant pleiotropy in 2 of the ratios. This study reveals novel insights into the metabolic basis of MSGCs, demonstrating significant associations between specific FAMRs and MSGCs risk. These findings highlight the potential clinical relevance of FAMRs as biomarkers or therapeutic targets in MSGCs. Future studies should focus on diverse populations and mechanistic research to validate these associations and explore their clinical implications.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041802","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:03:33Z","timestamp":1742310213000},"page":"e41802","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the potential causal relationship between fatty acid metabolism ratios and major salivary gland carcinomas: A two-sample Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6602-033X","authenticated-orcid":false,"given":"Yongjie","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Maxillofacial Surgery, Wei Fang People\u2019s Hospital, Wei Fang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Intervention, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqing","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Wei Fang People\u2019s Hospital, Wei Fang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Stomatology, Shandong Second Medical University, Wei Fang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchao","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Stomatology, Shandong Second Medical University, Wei Fang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopo","family":"He","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Wei Fang People\u2019s Hospital, Wei Fang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00405-022-07599-x","article-title":"Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study.","volume":"280","author":"Zhang","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-05-1125","article-title":"Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP\/CREB regulated genes.","volume":"65","author":"Coxon","year":"2005","journal-title":"Cancer Res"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.otc.2015.12.001","article-title":"Parotid gland tumors and the facial nerve.","volume":"49","author":"Gandolfi","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hed.23350","article-title":"Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the surveillance, epidemiology, and end results database.","volume":"36","author":"Jayaprakash","year":"2014","journal-title":"Head Neck"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.path.2020.09.010","article-title":"Salivary duct carcinoma: an aggressive salivary gland carcinoma with morphologic variants, newly identified molecular characteristics, and emerging treatment modalities.","volume":"14","author":"Rahman","year":"2021","journal-title":"Surg Pathol Clin"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"e35751","DOI":"10.1097\/MD.0000000000035751","article-title":"A retrospective study of nonneoplastic and neoplastic disorders of the salivary glands.","volume":"102","author":"Vamesu","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.3390\/molecules23102583","article-title":"The various roles of fatty acids.","volume":"23","author":"de Carvalho","year":"2018","journal-title":"Molecules"},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","article-title":"Tumour fatty acid metabolism in the context of therapy resistance and obesity.","volume":"21","author":"Hoy","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention.","volume":"159","author":"Butler","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-016-0163-7","article-title":"Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration.","volume":"5","author":"Balaban","year":"2017","journal-title":"Cancer Metab"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ijc.30903","article-title":"A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer.","volume":"141","author":"Lin","year":"2017","journal-title":"Int J Cancer"},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications.","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers.","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","article-title":"A generalized linear mixed model association tool for biobank-scale data.","volume":"53","author":"Jiang","year":"2021","journal-title":"Nat Genet"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamaneurol.2023.4929","article-title":"Risk factors for young-onset dementia in the UK biobank.","volume":"81","author":"Hendriks","year":"2024","journal-title":"JAMA Neurol"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/bioinformatics\/btz749","article-title":"Bayesian weighted Mendelian randomization for causal inference based on summary statistics.","volume":"36","author":"Zhao","year":"2020","journal-title":"Bioinformatics"},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"eabo0264","DOI":"10.1126\/scisignal.abo0264","article-title":"Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity.","volume":"15","author":"Cooke","year":"2022","journal-title":"Sci Signal"},{"key":"R19-20260108","first-page":"27","article-title":"Lipid metabolism reprogramming and its potential targets in cancer.","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10409238.2018.1442408","article-title":"Protein kinase C: perfectly balanced.","volume":"53","author":"Newton","year":"2018","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1073\/pnas.1912684117","article-title":"Live-cell lipid biochemistry reveals a role of diacylglycerol side-chain composition for cellular lipid dynamics and protein affinities.","volume":"117","author":"Schuhmacher","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The inositol trisphosphate\/calcium signaling pathway in health and disease.","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol Rev"},{"key":"R23-20260108","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/01635581.2016.1206582","article-title":"Effects of serum triglycerides on prostate cancer and breast cancer risk: a meta-analysis of prospective studies.","volume":"68","author":"Ma","year":"2016","journal-title":"Nutr Cancer"},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"djw167","DOI":"10.1093\/jnci\/djw167","article-title":"Pleiotropic analysis of lung cancer and blood triglycerides.","volume":"108","author":"Zuber","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R25-20260108","first-page":"291","article-title":"Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study.","volume":"22","author":"Borena","year":"2011","journal-title":"Cancer Causes Control"},{"key":"R26-20260108","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3390\/ijms23084300","article-title":"Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL).","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R27-20260108","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2016.11.033","article-title":"VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis.","volume":"388","author":"Lu","year":"2017","journal-title":"Cancer Lett"},{"key":"R28-20260108","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.coph.2012.07.006","article-title":"Cholesterol and prostate cancer.","volume":"12","author":"Pelton","year":"2012","journal-title":"Curr Opin Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:00:44Z","timestamp":1767906044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041802","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}